Home » Topics » Regulatory » Patents

Patents
RSS

Agents for HIV, tumors and autoimmune diseases from Boehringer Mannheim

June 6, 1997

Fibrinogen antagonists from Merck & Co.

June 6, 1997

Preparation and use of 5alpha-reductase type 1 inhibitors described by Merck & Co.

June 6, 1997

Takeda describes GnRH antagonists

June 6, 1997

Fujisawa discloses agents for bone metabolism disorders

June 6, 1997

NEP/ACE/ECE inhibitors described by Wakamoto

June 4, 1997

U. of California discloses mammalian EPO-BP

June 4, 1997

Anti E- and P-selectin antibodies from PDL

June 4, 1997

Tanabe Seiyaku reveals new ET antagonists

June 3, 1997

Nippon Kayaku discovers new antitumor agent

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...